Pristimerin drives ROS-dependent apoptosis in cutaneous T-cell lymphoma via inhibition of the AKT–SKP2 axis
Author:
Shilpa Kuttikrishnan,Rasheeda Anver,Fareed Ahmad,Zahwa Mariyam,Ummu Habeeba,Sabah Akhtar,Israa Salameh,Shahid S. Siddiqui,Kirti S. Prabu,Abdul W. Ansari,Ajaz A. Bhat,Abdul Q. Khan,Shahab Uddin
Publication:
Toxicology and Applied Pharmacology
© 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.